Webcast Alert: Executives from Aastrom Biosciences, BioCryst Pharmaceuticals, Dendreon, Genentech and Spectrum Pharmaceuticals Will Present at Informed Investors Biotech/Cancer Stocks Forum to be Webcast on Tuesday, December 16, 2003, 9 AM ET
What: Aastrom Biosciences, Inc. (Nasdaq: ASTM - ), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX - ), Dendreon Corp. (Nasdaq: DNDN - ), Genentech (NYSE: DNA - ), and Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI - ) will give presentations at Informed Investors Biotech/Cancer Stocks Forum When: December 16, 2003 @ 9:00 AM Eastern Time Where: http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296 How: Live over the Internet -- Simply log on to the web at the address above. Contacts: Aastrom Biosciences -- Investor Relations, 734-930-5777, firstname.lastname@example.org BioCryst Pharmaceuticals -- Michael A. Darwin, 205-444-4600, email@example.com Dendreon -- Julie Rathbun, Investor Relations, (206) 829-1500 Genentech -- Diane Schrick, 650-225-1599, firstname.lastname@example.org Spectrum Pharmaceuticals -- Anna Kazanchy, email@example.com
If you are unable to participate during the live webcast, the call will be available for replay at http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=296.
Aastrom Biosciences, Inc. is a late-stage development company focused on human cell-based therapies.
BioCryst Pharmaceuticals, Inc. designs and develops novel drugs that block key enzymes essential to disease progression.
Dendreon Corporation is a biotechnology company developing targeted therapies for cancer.
Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.
Spectrum Pharmaceuticals' primary focus is to develop in-licensed drugs for the treatment and supportive care of cancer patients.
FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424, firstname.lastname@example.org